Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Carbene Insertion. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Rh(I) catalyzed asymmetric B-H insertion for high-purity chiral boranes. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN115385948A discloses silicon-centered spiro-bisoxazoline ligands enabling high-yield asymmetric carbene insertion. Ideal for reliable pharmaceutical intermediate supplier needs.
Patent CN113087714B discloses a novel Rh(II)-catalyzed N-H insertion method for axial chiral aryl indole carbazoles, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.